Targeted Oncology: Highlighting current advances for the treatment of myeloproliferative neoplasms
January 28, 2020
Ruben Mesa discusses the current state of the treatment landscape for patients with myeloproliferative neoplasms (MPNs).
Category
January 28, 2020
Ruben Mesa discusses the current state of the treatment landscape for patients with myeloproliferative neoplasms (MPNs).
January 27, 2020
Ruben Mesa, MD, director of Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, discusses the impact myelofibrosis has on patients’ quality of life while at the American Society of Hematology conference.
January 27, 2020
UT Health San Antonio has launched an intensive out-patient program for veterans suffering from post-traumatic stress disorder following the devastation caused by Hurricane Harvey.
January 24, 2020
Dr. Robyn Scherber,created an assessment form to help patients with myeloproliferative neoplasms explain their symptoms to their care team.
January 23, 2020
UT Health San Antonio and The University of Texas at San Antonio (UTSA) are starting a fast-track degree program for future respiratory therapists, a job that’s increasingly in demand.
January 23, 2020
Dr. Jason Bowling, an associate professor of infectious diseases at UT Health San Antonio, tells KSAT’s Jessie Degollado that the U.S. has “no need to panic right now” amid international efforts to contain the coronavirus, a respiratory disease, that began in China. There is one coronavirus patient in the U.S. who is recovering in Seattle. […]